Prevention of malignant melanoma;Prävention des malignen melanoms

Onkologe

Volumn 18, Issue 3, 2012, Pages 224-229

  Bauer, J ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atypical nevi; Dermoscopy; Melanoma; Prevention; Risk factors

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPILUMINESCENCE MICROSCOPY; FOLLOW UP; GERMANY; HIGH RISK PATIENT; HUMAN; MELANOMA; PRIMARY PREVENTION; PUBLIC HEALTH INSURANCE; RADIATION PROTECTION; SECONDARY PREVENTION; ULTRAVIOLET RADIATION;

EID: 84863100884     PISSN: 09478965     EISSN: 14330415     Source Type: Journal    
DOI: 10.1007/s00761-011-2096-7     Document Type: Article

References (35)

1. Argenziano G, Soyer H (2001) Dermoscopy of pigmented skin lesions - a valuable tool for early diagnosis of melanoma. Lancet Oncol 2:443-449 (Pubitemid 33585949)
2. Autier P (2005) Cutaneous malignant melanoma: facts about sunbeds and sunscreen. Expert Rev Anticancer Ther 5:821-833 (Pubitemid 41599958)
3. Bauer J, Garbe C (2004) Risk estimation for malignant transformation of melanocytic nevi. Arch Dermatol 140:127 (Pubitemid 38090284)
4. Bauer J, Blum A, Strohhacker U, Garbe C (2005) Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol 152:87-92
5. Bauer J, Buttner P, Wiecker TS et al (2005) Interventional study in 1, 232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. Int J Cancer 116:755-761 (Pubitemid 41099706)
6. Bauer J, Buttner P, Wiecker TS et al (2005) Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1, 232 young German children. Int J Cancer 115:121-126 (Pubitemid 40559676)
7. Brantsch KD, Meisner C, Schonfisch B et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9:713-720
8. Bundesministerium für Gesundheit (2008) Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Änderung der Krebsfrüherkennungs-Richtlinien: Hautkrebs-Screening. Bundesanzeiger 37:871
9. Carli P, Biggeri A, Giannotti B (1995) Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol 32:734-739
10. Clark W H J, Reimer RR, Greene M et al (1978) Origin of familial malignant melanomas from heritable melanocytic lesions.' The B-K mole syndrome'. Arch Dermatol 114:732-738
11. Freedberg KA, Geller AC, Miller DR et al (1999) Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 41:738-745 (Pubitemid 29514030)
12. Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040-2059 (Pubitemid 41337946)
13. Garbe C, Buttner P, Weiss J et al (1994) Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: multicenter case-control study of the central malignant melanoma registry of the German dermatological society. J Invest Dermatol 102:700-705 (Pubitemid 24144246)
14. Garbe C, Buttner P, Weiss J et al (1994) Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German dermatological society. J Invest Dermatol 102:695-699 (Pubitemid 24144245)
15. Geller AC, Greinert R, Sinclair C et al (2010) A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol 34:355-358
16. Green A, MacLennan R, Siskind V (1985) Common acquired naevi and the risk of malignant melanoma. Int J Cancer 35:297-300 (Pubitemid 15010649)
17. Greene MH, Clark W H J, Tucker MA et al (1985) High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 102:458-465 (Pubitemid 15109001)
18. Greinert R, Volkmer B, Wende A et al (2003) Prevention of skin cancer. Necessity, implementation and success. Hautarzt 54:1152-1163 (Pubitemid 37522360)
19. Hansen CB, Wadge LM, Lowstuter K et al (2004) Clinical germline genetic testing for melanoma. Lancet Oncol 5:314-319 (Pubitemid 38541583)
20. Husmann G, Kaatscht P, Katalinitsch A et al (2010) Krebs in Deutschland 2005/2006. Robert Koch-Institut, Berlin
21. International Agency for Research on Cancer Working Group on Artificial Ultraviolet (UV) Light and Skin Cancer (2007) The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int J Cancer 120:1116-1122
22. Kittler H, Guitera P, Riedl E et al (2006) Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 142:1113-1119 (Pubitemid 44414394)
23. Kraemer KH, Tucker M, Tarone R et al (1986) Risk of cutaneous melanoma in dysplastic nevus syndrome types A and B. N Engl J Med 315:1615-1616 (Pubitemid 17055405)
24. Landi MT, Bauer J, Pfeiffer RM et al (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313:521-522 (Pubitemid 44148456)
25. Lynch HT, Frichot BC 3, Lynch JF (1978) Familial atypical multiple mole-melanoma syndrome. J Med Genet 15:352-356 (Pubitemid 9041252)
26. Mackie RM, Aitchison T (1982) Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 46:955-960 (Pubitemid 13177704)
27. Mackie RM, Freudenberger T, Aitchison TC (1989) Personal risk-factor chart for cutaneous melanoma. Lancet 2:487-490 (Pubitemid 19209152)
28. Mackie RM, McHenry P, Hole D (1993) Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet 341:1618-1620 (Pubitemid 23175245)
29. Reimer RR, Clark W H J, Greene MH et al (1978) Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA 239:744-746 (Pubitemid 8276472)
30. Rodenas JM, Delgado-Rodriguez M, Farinas-Alvarez C et al (1997) Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol 145:1020-1029 (Pubitemid 27215485)
31. Steinmann A, Liebl B (2004) Prevention and early detection of cancer of the skin. Gesundheitswesen [Suppl 1] 66:S37-S42
32. Swerdlow AJ, English J, Mackie RM et al (1986) Benign melanocytic naevi as a risk factor for malignant melanoma. BMJ 292:1555-1559 (Pubitemid 16080835)
33. Thaler AK von, Kamenisch Y, Berneburg M (2010) The role of ultraviolet radiation in melanomagenesis. Exp Dermatol 19:81-88
34. Tsao H, Bevona C, Goggins W, Quinn T (2003) The transformation rate of moles (melanocytic nevi) into cutaneous melanoma. A population based estimate. Arch Dermatol 139:282-288 (Pubitemid 36330574)
35. Tucker MA, Halpern A, Holly EA et al (1997) Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277:1439-1444 (Pubitemid 27208885)